Search Results - "Ray, Mukti"

Antituberculosis activity of polyphenols of Areca catechu by Raju, Archana, De, Suparna, Ray, Mukti, Degani, Mariam

“…Background: Polyphenols have been studied for their potential involvement in the prevention of various chronic diseases as well as for their antimicrobial…”
Get full text

On the Optimization of the Protocol for Automated Radiosyntheses of [68Ga]Ga-Pentixafor, [68Ga]Ga-FAPI-4 and [68Ga]Ga-DOTATATE in a Modular-Lab Standard by Menon, Sreeja Raj, Mitra Arpit, Sahu Sudeep, Lad Sangita, Chakraborty Avik, Ray, Mukti Kanta, Banerjee Sharmila

“…Objective(s): The present work describes the automated radiochemical synthesis of different PET tracers like [68Ga]Ga-Pentixafor, [68Ga]Ga-FAPI-4 and…”
Get full text

Design and synthesis of 5‐(5‐nitrothiophen‐2‐yl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazole derivatives with improved solubility and potential antituberculosis activity by Khambete, Mihir, Kundaikar, Harish, Raju, Archana, Lonkar, Sachin, Degani, Mariam, Ray, Mukti Kanta

“…We report the design‐synthesis of several nitrothiophene containing molecules as antituberculosis agents. The molecules were designed on the basis of…”
Get full text

Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3 by Tawate, Megha, Mitra, Arpit, Chakraborty, Avik, Lad, Sangeeta, Gaikwad, Sujay, Sahu, Sudeep, Rakshit, Sutapa, Menon, Sreeja, Ray, Mukti Kant, Damle, Archana, Banerjee, Sharmila

Get full text

P-297 - Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model by Sahu, Sudeep, Tawate, Megha, Lad, Sangeeta, Chakraborty, Avik, Mitra, Arpit, Rakshit, Sutapa, Upadhye, Trupti, Wanage, Gaurav, Ray, Mukti Kant, Damle, Archana, Kulkarni, Savita, Baghel, Nawab

Get full text

Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model by Sahu, Sudeep, Tawate, Megha, Lad, Sangeeta, Chakraborty, Avik, Mitra, Arpit, Rakshit, Sutapa, Upadhye, Trupti, Wanage, Gaurav, Ray, Mukti Kant, Damle, Archana, Kulkarni, Savita, Baghel, Nawab

Get full text

Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation by Sahu, Sudeep, Tawate, Megha, Lad, Sangeeta, Chakraborty, Avik, Mitra, Arpit, Rakshit, Sutapa, Upadhye, Trupti, Wanage, Gaurav, Ray, Mukti Kant, Damle, Archana, Kulkarni, Savita, Baghel, Nawab

Get full text

In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor by Tawate, Megha, Chakraborty, Avik, Mitra, Arpit, Lad, Sangeeta, Gaikwad, Sujay, Sahu, Sudeep, Upadhye, Trupti, Rakshit, Sutapa, Menon, Sreeja, Ray, Mukti Kant, Damle, Archana, Banerjee, Sharmila

Get full text

P-176 - Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3 by Tawate, Megha, Mitra, Arpit, Chakraborty, Avik, Lad, Sangeeta, Gaikwad, Sujay, Sahu, Sudeep, Rakshit, Sutapa, Menon, Sreeja, Ray, Mukti Kant, Damle, Archana, Banerjee, Sharmila

Get full text

P-301 - In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor by Tawate, Megha, Chakraborty, Avik, Mitra, Arpit, Lad, Sangeeta, Gaikwad, Sujay, Sahu, Sudeep, Upadhye, Trupti, Rakshit, Sutapa, Menon, Sreeja, Ray, Mukti Kant, Damle, Archana, Banerjee, Sharmila

Get full text

P-298 - Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation by Sahu, Sudeep, Tawate, Megha, Lad, Sangeeta, Chakraborty, Avik, Mitra, Arpit, Rakshit, Sutapa, Upadhye, Trupti, Wanage, Gaurav, Ray, Mukti Kant, Damle, Archana, Kulkarni, Savita, Baghel, Nawab

Get full text

Automated radiosynthesis of pharmaceutical grade [68Ga]Ga-NODAGA-Lys40-Exendin-4 and demonstration of its efficacy for use in patients by Menon, Sreeja Raj, Mitra, Arpit, Chakraborty, Avik, Kamaldeep, Sahu, Sudeep, Tawate, Megha, Lad, Sangita, Rakshit, Sutapa, Upadhye, Trupti, Ray, Mukti Kanta, Banerjee, Sharmila

“…The radiosynthesis of pharmaceutical grade [ 68 Ga]Ga-NODAGA-Lys 40 -Exendin-4 was accomplished in a fixed tubing-based module, EZ Modular-Lab Standard…”
Get full text

Synthesis and mycobacterial evaluation of 5‐substituted‐6‐acetyl‐2‐amino‐7‐methyl‐5,8‐dihydropyrido‐[2,3‐d]pyrimidin‐4(3H)‐one derivatives by Agre, Neha, Degani, Mariam, Gupta, Antima, Bhakta, Sanjib, Ray, Mukti Kanta

“…5‐Substituted‐6‐acetyl‐2‐amino‐7‐methyl‐5,8‐dihydropyrido[2,3‐d]pyrimidin‐4(3H)‐one derivatives were synthesized and evaluated against Mycobacterium…”
Get full text

Automated radiochemical synthesis of pharmaceutical grade [18F]FLT using 3‐N‐Boc‐5′‐O‐dimethoxytrityl‐3′‐O‐nosyl‐thymidine precursor and its Sep‐Pak® purification employing selective elution from reversed phase by Mitra, Arpit, Chakraborty, Avik, Upadhye, Trupti, Tawate, Megha, Lad, Sangita, Sahu, Sudeep, Rajesh, Chinagandham, Bagul, Swati, Pawar, Yogita, Ray, Mukti Kant, Banerjee, Sharmila

“…Pharmaceutical grade 3′‐deoxy‐3′‐[18F]fluorothymidine [18F]FLT was synthesized using 3‐N‐Boc‐5′‐O‐dimethoxytrityl‐3′‐O‐nosyl‐thymidine (BOC‐Nosyl) precursor,…”
Get full text

Design and synthesis of 5‐(5‐nitrothiophen‐2‐yl)‐3‐phenyl‐4,5‐dihydro‐1 H ‐pyrazole derivatives with improved solubility and potential antituberculosis activity by Khambete, Mihir, Kundaikar, Harish, Raju, Archana, Lonkar, Sachin, Degani, Mariam, Ray, Mukti Kanta

“…Abstract We report the design‐synthesis of several nitrothiophene containing molecules as antituberculosis agents. The molecules were designed on the basis of…”
Get full text

Intricacies in the Preparation of Patient Doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab Using Low Specific Activity [177Lu]LuCl3: Methodological Aspects by Chakraborty, Avik, Mitra, Arpit, Sahu, Sudeep, Tawate, Megha, Lad, Sangita, Kamaldeep, Rakshit, Sutapa, Upadhye Bannore, Trupti, Gaikwad, Sujay, Dhotre, Geetanjali, Ray, Mukti Kanta, Damle, Archana, Basu, Sandip, Banerjee, Sharmila

“…The development of humanized monoclonal antibodies (MAbs) with Lutetium-177 ([ 177 Lu]Lu 3+ ) has brought a paradigm shift in the arena of targeted therapy of…”
Get full text

Intricacies in the Preparation of Patient Doses of [ 177 Lu]Lu-Rituximab and [ 177 Lu]Lu-Trastuzumab Using Low Specific Activity [ 177 Lu]LuCl 3 : Methodological Aspects by Chakraborty, Avik, Mitra, Arpit, Sahu, Sudeep, Tawate, Megha, Lad, Sangita, Kamaldeep, Rakshit, Sutapa, Upadhye Bannore, Trupti, Gaikwad, Sujay, Dhotre, Geetanjali, Ray, Mukti Kanta, Damle, Archana, Basu, Sandip, Banerjee, Sharmila

“…The development of humanized monoclonal antibodies (MAbs) with Lutetium-177 ([ Lu]Lu ) has brought a paradigm shift in the arena of targeted therapy of various…”
Get full text

Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors by Shelke, Rupesh U., Degani, Mariam S., Raju, Archana, Ray, Mukti Kanta, Rajan, Mysore G. R.

“…Fragment‐based drug design was used to identify Mycobacterium tuberculosis (Mtb) dihydrofolate reductase (DHFR) inhibitors. Screening of ligands against the…”
Get full text

Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents by Tawari, Nilesh R, Bag, Seema, Raju, Archana, Lele, Arundhati C, Bairwa, Ranjeet, Ray, Mukti Kanta, Rajan, M G R, Nawale, Laxman U, Sarkar, Dhiman, Degani, Mariam S

“…A series of 2,4-diamino-s-triazines was designed, with potential for activity against Mycobacterium tuberculosis (Mtb) dihydrofolate reductase enzyme, on the…”
Get full text